Xiaolin Lu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review.

Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review.

Journal: Cancer management and research
Published: June 20, 2025

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

Journal: BMC medicine
Published: October 14, 2024

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.

Journal: Frontiers in oncology
Published: September 19, 2024

A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.

A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.

Journal: Cell death & disease
Published: November 10, 2023

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic.

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic.

Journal: Frontiers in public health
Published: July 20, 2022

Pazopanib together with 6-8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma.

Pazopanib together with 6-8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma.

Journal: Translational andrology and urology
Published: June 23, 2021

Prognosis of the 8th TNM Staging System for Penile Cancer and Refinement of Prognostication by Incorporating High Risk Human Papillomavirus Status.

Prognosis of the 8th TNM Staging System for Penile Cancer and Refinement of Prognostication by Incorporating High Risk Human Papillomavirus Status.

Journal: The Journal of urology
Published: October 10, 2019

AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.

AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.

Journal: Developmental cell
Published: May 22, 2018

Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Journal: Oncology letters
Published: April 18, 2018

SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

Journal: Oncology letters
Published: October 21, 2016

NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.

NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.

Journal: Oncology letters
Published: February 21, 2016

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.

Journal: Oncotarget
Published: December 23, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026